← Back to Search

Optimizing Video Communication Assessment for Teaching Error Disclosure Skills

N/A
Waitlist Available
Led By Andrew A White, MD, SFHM
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Enrolled in the second post-graduate year (PGY2) of an Internal Medicine or Family Medicine Residency
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the second of two time points for vca use (4 weeks after first use)
Awards & highlights
No Placebo-Only Group

Summary

The goal of this randomized, single-blinded, educational study is to test the effect of providing crowdsourced ratings and feedback to second-year (PGY2) internal medicine (IM) and family medicine (FM) resident physicians' about their adverse event communication skills. The main question it aims to answer is: - Is the intervention of providing reports with personal performance feedback and recommendations for effective error disclosure associated with higher ratings of resident error disclosure skills? Participants will perform simulated error disclosure with a software tool called the Video-based Communication Assessment (VCA). Participants will be randomized to receive feedback reports (intervention) or not (control). Participants receiving the intervention will be asked to review their feedback and all participants will use the VCA again approximately 4 weeks later with different patient cases.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before the second vca use (4 weeks after first use)
This trial's timeline: 3 weeks for screening, Varies for treatment, and before the second vca use (4 weeks after first use) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Summary crowdsourced rating
Secondary study objectives
Survey about VCA feedback use in intervention arm
Survey about prior disclosure experience

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will be provided with access to a feedback report in the VCA app that contains 1) crowdsourced ratings of their error disclosure communication, 2) access to recordings of their responses to the completed VCA cases, 3) a recording of a highly-rated peer response and 4) learning points summarizing what laypeople would like the doctor to say in response to the case.
Group II: ControlActive Control1 Intervention
Participants will not have access to a feedback report.

Find a Location

Who is running the clinical trial?

The National Board of Medical ExaminersOTHER
1 Previous Clinical Trials
189 Total Patients Enrolled
University of WashingtonLead Sponsor
1,824 Previous Clinical Trials
1,913,201 Total Patients Enrolled
Andrew A White, MD, SFHMPrincipal InvestigatorUniversity of Washington
~45 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top